© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
April 11, 2019
The real-world strategies used to manage the high cost of specialty meds.
April 10, 2019
The Trump Administration has taken a large interest in PBM drug rebates, which they say create higher drug prices. But do they?
January 30, 2019
Louisiana’s subscription model aims to rein in the hepatitis C epidemic in the state.
December 06, 2018
Here’s how experts predict healthcare will unfold in 2019.
December 01, 2018
The biosimilar market is flourishing in Europe-why aren’t we seeing similar gains in the U.S.?
November 13, 2018
The value and benefits of biosimilars are increasingly becoming more apparent. Here are four areas where they are growing the most.
October 25, 2018
Cancer medication spending is unsustainable, but significant savings can be achieved just by reducing waste. Here’s how.
October 24, 2018
How can payers cope with new, ultra-expensive therapies?
September 10, 2018
While promising new options keep entering the scene, high costs can be problematic to patients and healthcare organizations. Here are some ways to cope.
July 18, 2018
Drug costs are increasing, but so is patient cost sharing. That’s raising serious problems for some patients. Here are seven of the most out-of-reach drugs due to high costs, according to industry watchers.